Skip to main content
Erschienen in:

23.08.2024 | Retinal Disorders

Incidence and risk factors of fellow-eyes wet conversion in unilateral neovascular age-related macular degeneration over 15-year follow-up

verfasst von: Elham Sadeghi, Sharat Chandra Vupparaboina, Sandeep Chandra Bollepalli, Kiran Kumar Vupparaboina, Komal Agarwal, Jose-Alain Sahel, Andrew W. Eller, Jay Chhablani

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 1/2025

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Incidence and risk factors of fellow eye wet conversion in unilateral neovascular age-related macular degeneration (nAMD) over 15-years follow-up.

Methods

This retrospective study reviewed 593 unilateral nAMD patients with a minimum of five years up to 15 years of follow-up. The demographic data, visual acuity, fellow eye nAMD conversion rate, and the number of anti-vascular endothelial growth factor (anti-VEGF) injections in the primary eye were evaluated. Also, the nAMD-converted fellow eyes were divided into two groups based on the time of conversion (less and more than two years from the first injection in the primary eye). Based on the data types, the T-test, Chi-square, and Mann–Whitney U test were used to analyze.

Results

The total cases were 593 patients, and 248 eyes (41.82%) converted to nAMD in the mean interval of 34.92 ± 30.62 months. The males exhibited a predisposition to wet conversion at 2.54 years earlier than their female counterparts (P = 0.025). In all the converted fellow eyes, the mean age was 2.3 years higher at presentation in the group who converted within two years of follow-up in compared to eyes that converted after two years (79.82 ± 8.64 vs 77.51 ± 8.5 years, P = 0.035). Additionally, eyes converting within two years had a mean baseline LogMAR visual acuity of 0.44 ± 0.47, compared to 0.32 ± 0.41 for conversions after two years (P = 0.014).

Conclusion

This study reported that males showed a predisposition to fellow eye nAMD conversion at an earlier age. Additionally, there was a trend of faster fellow eye nAMD conversion in individuals with higher age and lower baseline visual acuity.

Key messages

What is known
• Certain risk factors may make the fellow eye of neovascular age-related macular degeneration (nAMD) more likely to progress to wet conversion.
• Identifying these risk factors for fellow eye wet conversion can help prevent it, potentially preserving the patient’s vision quality for a longer duration.
• The studies on the incidence of wet conversion in the fellow eye have yielded controversial results.
What is new
• During the 15-year follow-up period, nearly half (47.58%) of the fellow eyes that underwent wet conversion did so within the initial two years following the wet conversion of the first eye.
• Males showed a predisposition to fellow eye nAMD conversion at an earlier age.
• There was a trend of faster fellow eye nAMD conversion in individuals with higher age and lower baseline visual acuity.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2(2):e106–e116PubMedCrossRef Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2(2):e106–e116PubMedCrossRef
2.
Zurück zum Zitat Colijn JM, Buitendijk GH, Prokofyeva E, Alves D, Cachulo ML, Khawaja AP et al (2017) Prevalence of age-related macular degeneration in Europe: the past and the future. Ophthalmology 124(12):1753–1763PubMedCrossRef Colijn JM, Buitendijk GH, Prokofyeva E, Alves D, Cachulo ML, Khawaja AP et al (2017) Prevalence of age-related macular degeneration in Europe: the past and the future. Ophthalmology 124(12):1753–1763PubMedCrossRef
3.
Zurück zum Zitat Shinojima A, Sawa M, Mori R, Sekiryu T, Oshima Y, Kato A et al (2020) Five-year follow-up of fundus autofluorescence and retinal sensitivity in the fellow eye in exudative age-related macular degeneration in Japan. PLoS ONE 15(3):e0229694PubMedPubMedCentralCrossRef Shinojima A, Sawa M, Mori R, Sekiryu T, Oshima Y, Kato A et al (2020) Five-year follow-up of fundus autofluorescence and retinal sensitivity in the fellow eye in exudative age-related macular degeneration in Japan. PLoS ONE 15(3):e0229694PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd (2005) Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology 112(4):533–9PubMedCrossRef Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd (2005) Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology 112(4):533–9PubMedCrossRef
5.
Zurück zum Zitat Pennington KL, DeAngelis MM (2016) Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye Vis (Lond) 3:34PubMedCrossRef Pennington KL, DeAngelis MM (2016) Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye Vis (Lond) 3:34PubMedCrossRef
6.
Zurück zum Zitat Thomas CJ, Mirza RG, Gill MK (2021) Age-related macular degeneration. Med Clin North Am 105(3):473–491PubMedCrossRef Thomas CJ, Mirza RG, Gill MK (2021) Age-related macular degeneration. Med Clin North Am 105(3):473–491PubMedCrossRef
7.
Zurück zum Zitat Csaky KG, Schachat AP, Kaiser PK, Small KW, Heier JS (2017) The use of genetic testing in the management of patients with age-related macular degeneration: American Society of Retina Specialists Genetics Task Force Special Report. J VitreoRetinal Dis 1(1):75–78CrossRef Csaky KG, Schachat AP, Kaiser PK, Small KW, Heier JS (2017) The use of genetic testing in the management of patients with age-related macular degeneration: American Society of Retina Specialists Genetics Task Force Special Report. J VitreoRetinal Dis 1(1):75–78CrossRef
8.
Zurück zum Zitat Amissah-Arthur KN, Panneerselvam S, Narendran N, Yang YC (2012) Optical coherence tomography changes before the development of choroidal neovascularization in second eyes of patients with bilateral wet macular degeneration. Eye 26(3):394–399PubMedCrossRef Amissah-Arthur KN, Panneerselvam S, Narendran N, Yang YC (2012) Optical coherence tomography changes before the development of choroidal neovascularization in second eyes of patients with bilateral wet macular degeneration. Eye 26(3):394–399PubMedCrossRef
9.
Zurück zum Zitat Sakurada Y, Sugiyama A, Kikushima W, Yoneyama S, Tanabe N, Matsubara M, Iijima H (2019) Pseudodrusen pattern and development of late age-related macular degeneration in the fellow eye of the unilateral case. Jpn J Ophthalmol 63(5):374–381PubMedCrossRef Sakurada Y, Sugiyama A, Kikushima W, Yoneyama S, Tanabe N, Matsubara M, Iijima H (2019) Pseudodrusen pattern and development of late age-related macular degeneration in the fellow eye of the unilateral case. Jpn J Ophthalmol 63(5):374–381PubMedCrossRef
10.
Zurück zum Zitat Yanagi Y, Mohla A, Lee SY, Mathur R, Chan CM, Yeo I et al (2018) Incidence of fellow eye involvement in patients with unilateral exudative age-related macular degeneration. JAMA Ophthalmol 136(8):905–911PubMedPubMedCentralCrossRef Yanagi Y, Mohla A, Lee SY, Mathur R, Chan CM, Yeo I et al (2018) Incidence of fellow eye involvement in patients with unilateral exudative age-related macular degeneration. JAMA Ophthalmol 136(8):905–911PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Gangnon RE, Lee KE, Klein BE, Iyengar SK, Sivakumaran TA, Klein R (2015) Severity of age-related macular degeneration in 1 eye and the incidence and progression of age-related macular degeneration in the fellow eye: the Beaver Dam Eye Study. JAMA Ophthalmol 133(2):125–132PubMedPubMedCentralCrossRef Gangnon RE, Lee KE, Klein BE, Iyengar SK, Sivakumaran TA, Klein R (2015) Severity of age-related macular degeneration in 1 eye and the incidence and progression of age-related macular degeneration in the fellow eye: the Beaver Dam Eye Study. JAMA Ophthalmol 133(2):125–132PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Palejwala NV, Jia Y, Gao SS, Liu L, Flaxel CJ, Hwang TS et al (2015) Detection of non-exudative choroidal neovascularization in age-related macular degeneration with optical coherence tomography angiography. Retina (Philadelphia, Pa) 35(11):2204PubMedCrossRef Palejwala NV, Jia Y, Gao SS, Liu L, Flaxel CJ, Hwang TS et al (2015) Detection of non-exudative choroidal neovascularization in age-related macular degeneration with optical coherence tomography angiography. Retina (Philadelphia, Pa) 35(11):2204PubMedCrossRef
13.
Zurück zum Zitat Roisman L, Zhang Q, Wang RK, Gregori G, Zhang A, Chen C-L et al (2016) Optical coherence tomography angiography of asymptomatic neovascularization in intermediate age-related macular degeneration. Ophthalmology 123(6):1309–1319PubMedCrossRef Roisman L, Zhang Q, Wang RK, Gregori G, Zhang A, Chen C-L et al (2016) Optical coherence tomography angiography of asymptomatic neovascularization in intermediate age-related macular degeneration. Ophthalmology 123(6):1309–1319PubMedCrossRef
14.
Zurück zum Zitat Yanagi Y, Mohla A, Lee W-K, Lee SY, Mathur R, Chan CM et al (2017) Prevalence and risk factors for nonexudative neovascularization in fellow eyes of patients with unilateral age-related macular degeneration and polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 58(9):3488–3495PubMedCrossRef Yanagi Y, Mohla A, Lee W-K, Lee SY, Mathur R, Chan CM et al (2017) Prevalence and risk factors for nonexudative neovascularization in fellow eyes of patients with unilateral age-related macular degeneration and polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 58(9):3488–3495PubMedCrossRef
15.
Zurück zum Zitat Bek T, Klug SE (2018) Incidence and risk factors for neovascular age-related macular degeneration in the fellow eye. Graefes Arch Clin Exp Ophthalmol 256(11):2061–2068PubMedCrossRef Bek T, Klug SE (2018) Incidence and risk factors for neovascular age-related macular degeneration in the fellow eye. Graefes Arch Clin Exp Ophthalmol 256(11):2061–2068PubMedCrossRef
16.
Zurück zum Zitat Ueta T, Iriyama A, Francis J, Takahashi H, Adachi T, Obata R et al (2008) Development of typical age-related macular degeneration and polypoidal choroidal vasculopathy in fellow eyes of Japanese patients with exudative age-related macular degeneration. Am J Ophthalmol 146(1):96-101. e2PubMedCrossRef Ueta T, Iriyama A, Francis J, Takahashi H, Adachi T, Obata R et al (2008) Development of typical age-related macular degeneration and polypoidal choroidal vasculopathy in fellow eyes of Japanese patients with exudative age-related macular degeneration. Am J Ophthalmol 146(1):96-101. e2PubMedCrossRef
17.
Zurück zum Zitat Bochicchio S, Xhepa A, Secondi R, Acquistapace A, Oldani M, Cigada MV et al (2019) The incidence of neovascularization in the fellow eye of patients with unilateral choroidal lesion: a survival analysis. Ophthalmol Retina 3(1):27–31PubMedCrossRef Bochicchio S, Xhepa A, Secondi R, Acquistapace A, Oldani M, Cigada MV et al (2019) The incidence of neovascularization in the fellow eye of patients with unilateral choroidal lesion: a survival analysis. Ophthalmol Retina 3(1):27–31PubMedCrossRef
18.
Zurück zum Zitat Burgess DB, Jefferys JL (1993) Extrafoveal choroidal neovascularization. Arch Ophthalmol 111:1189–1199 Burgess DB, Jefferys JL (1993) Extrafoveal choroidal neovascularization. Arch Ophthalmol 111:1189–1199
19.
Zurück zum Zitat Tufail A, Xing W, Johnston R, Akerele T, McKibbin M, Downey L et al (2014) The neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections. Ophthalmology 121(5):1092–1101CrossRef Tufail A, Xing W, Johnston R, Akerele T, McKibbin M, Downey L et al (2014) The neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections. Ophthalmology 121(5):1092–1101CrossRef
20.
Zurück zum Zitat Zarranz-Ventura J, Liew G, Johnston RL, Xing W, Akerele T, McKibbin M et al (2014) The neovascular age-related macular degeneration database: report 2: incidence, management, and visual outcomes of second treated eyes. Ophthalmology 121(10):1966–1975PubMedCrossRef Zarranz-Ventura J, Liew G, Johnston RL, Xing W, Akerele T, McKibbin M et al (2014) The neovascular age-related macular degeneration database: report 2: incidence, management, and visual outcomes of second treated eyes. Ophthalmology 121(10):1966–1975PubMedCrossRef
21.
Zurück zum Zitat Fasler K, Fu DJ, Moraes G, Wagner S, Gokhale E, Kortuem K et al (2020) Moorfields AMD database report 2: fellow eye involvement with neovascular age-related macular degeneration. Br J Ophthalmol 104(5):684–690PubMedCrossRef Fasler K, Fu DJ, Moraes G, Wagner S, Gokhale E, Kortuem K et al (2020) Moorfields AMD database report 2: fellow eye involvement with neovascular age-related macular degeneration. Br J Ophthalmol 104(5):684–690PubMedCrossRef
22.
Zurück zum Zitat Yuzawa M, Hagita K, Egawa T, Minato H, Matsui M (1991) Macular lesions predisposing to senile disciform macular degeneration. Jpn J Ophthalmol 35(1):87–95PubMed Yuzawa M, Hagita K, Egawa T, Minato H, Matsui M (1991) Macular lesions predisposing to senile disciform macular degeneration. Jpn J Ophthalmol 35(1):87–95PubMed
23.
Zurück zum Zitat Burgess D, Hawkins B, Jefferys J (1993) Macular Photocoagulation Study Group: five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol 111:1189–1199CrossRef Burgess D, Hawkins B, Jefferys J (1993) Macular Photocoagulation Study Group: five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol 111:1189–1199CrossRef
24.
Zurück zum Zitat Sandberg MA, Weiner A, Miller S, Gaudio AR (1998) High-risk characteristics of fellow eyes of patients with unilateral neovascular age-related macular degeneration. Ophthalmology 105(3):441–447PubMedCrossRef Sandberg MA, Weiner A, Miller S, Gaudio AR (1998) High-risk characteristics of fellow eyes of patients with unilateral neovascular age-related macular degeneration. Ophthalmology 105(3):441–447PubMedCrossRef
25.
Zurück zum Zitat Uyama M, Takahashi K, Ida N, Miyashiro M, Ando A, Takahashi A et al (2000) The second eye of Japanese patients with unilateral exudative age related macular degeneration. Br J Ophthalmol 84(9):1018–1023PubMedPubMedCentralCrossRef Uyama M, Takahashi K, Ida N, Miyashiro M, Ando A, Takahashi A et al (2000) The second eye of Japanese patients with unilateral exudative age related macular degeneration. Br J Ophthalmol 84(9):1018–1023PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Bhisitkul RB, Desai SJ, Boyer DS, Sadda SR, Zhang K (2016) Fellow eye comparisons for 7-year outcomes in ranibizumab-treated AMD subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study). Ophthalmology 123(6):1269–1277PubMedCrossRef Bhisitkul RB, Desai SJ, Boyer DS, Sadda SR, Zhang K (2016) Fellow eye comparisons for 7-year outcomes in ranibizumab-treated AMD subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study). Ophthalmology 123(6):1269–1277PubMedCrossRef
27.
Zurück zum Zitat Buch H, Nielsen NV, Vinding T, Jensen GB, Prause JU, la Cour M (2005) 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study. Ophthalmology 112(5):787–798PubMedCrossRef Buch H, Nielsen NV, Vinding T, Jensen GB, Prause JU, la Cour M (2005) 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study. Ophthalmology 112(5):787–798PubMedCrossRef
28.
Zurück zum Zitat Laitinen A, Laatikainen L, Härkänen T, Koskinen S, Reunanen A, Aromaa A (2010) Prevalence of major eye diseases and causes of visual impairment in the adult Finnish population: a nationwide population-based survey. Acta Ophthalmol 88(4):463–471PubMedCrossRef Laitinen A, Laatikainen L, Härkänen T, Koskinen S, Reunanen A, Aromaa A (2010) Prevalence of major eye diseases and causes of visual impairment in the adult Finnish population: a nationwide population-based survey. Acta Ophthalmol 88(4):463–471PubMedCrossRef
29.
Zurück zum Zitat Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG (2012) Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 119(3):571–580PubMedCrossRef Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG (2012) Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 119(3):571–580PubMedCrossRef
30.
Zurück zum Zitat Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G et al (2010) Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 10:1–13CrossRef Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G et al (2010) Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 10:1–13CrossRef
31.
Zurück zum Zitat Snow KK, Cote J, Yang W, Davis NJ, Seddon JM (2002) Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women. Am J Ophthalmol 134(6):842–848PubMedCrossRef Snow KK, Cote J, Yang W, Davis NJ, Seddon JM (2002) Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women. Am J Ophthalmol 134(6):842–848PubMedCrossRef
32.
Zurück zum Zitat Smith W, Mitchell P, Wang J (1997) Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol 25(4):13–15CrossRef Smith W, Mitchell P, Wang J (1997) Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol 25(4):13–15CrossRef
34.
Zurück zum Zitat Kuroda Y, Yamashiro K, Miyake M, Yoshikawa M, Nakanishi H, Oishi A et al (2015) Factors associated with recurrence of age-related macular degeneration after anti-vascular endothelial growth factor treatment: a retrospective cohort study. Ophthalmology 122(11):2303–2310PubMedCrossRef Kuroda Y, Yamashiro K, Miyake M, Yoshikawa M, Nakanishi H, Oishi A et al (2015) Factors associated with recurrence of age-related macular degeneration after anti-vascular endothelial growth factor treatment: a retrospective cohort study. Ophthalmology 122(11):2303–2310PubMedCrossRef
35.
Zurück zum Zitat Suzuki M, Kamei M, Itabe H, Yoneda K, Bando H, Kume N, Tano Y (2007) Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration. Mol Vis 13:772–778PubMedPubMedCentral Suzuki M, Kamei M, Itabe H, Yoneda K, Bando H, Kume N, Tano Y (2007) Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration. Mol Vis 13:772–778PubMedPubMedCentral
36.
Zurück zum Zitat Deng Y, Qiao L, Du M, Qu C, Wan L, Li J, Huang L (2022) Age-related macular degeneration: epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy. Genes Dis 9(1):62–79PubMedCrossRef Deng Y, Qiao L, Du M, Qu C, Wan L, Li J, Huang L (2022) Age-related macular degeneration: epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy. Genes Dis 9(1):62–79PubMedCrossRef
37.
Zurück zum Zitat Pons M, Marin-Castaño ME (2011) Nicotine increases the VEGF/PEDF ratio in retinal pigment epithelium: a possible mechanism for CNV in passive smokers with AMD. Invest Ophthalmol Vis Sci 52(6):3842–3853PubMedPubMedCentralCrossRef Pons M, Marin-Castaño ME (2011) Nicotine increases the VEGF/PEDF ratio in retinal pigment epithelium: a possible mechanism for CNV in passive smokers with AMD. Invest Ophthalmol Vis Sci 52(6):3842–3853PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Chakravarthy U, Augood C, Bentham GC, de Jong PTVM, Rahu M, Seland J et al (2007) Cigarette smoking and age-related macular degeneration in the EUREYE Study. Ophthalmology 114(6):1157–1163PubMedCrossRef Chakravarthy U, Augood C, Bentham GC, de Jong PTVM, Rahu M, Seland J et al (2007) Cigarette smoking and age-related macular degeneration in the EUREYE Study. Ophthalmology 114(6):1157–1163PubMedCrossRef
39.
Zurück zum Zitat Wang Y, Zhang T, Mao S, Rappaport TS (2021) Directional neighbor discovery in mmWave wireless networks. Digit Commun Netw 7(1):1–15CrossRef Wang Y, Zhang T, Mao S, Rappaport TS (2021) Directional neighbor discovery in mmWave wireless networks. Digit Commun Netw 7(1):1–15CrossRef
40.
Zurück zum Zitat Liu L, Li C, Yu H, Yang X (2022) A critical review on air pollutant exposure and age-related macular degeneration. Sci Total Environ 840:156717PubMedCrossRef Liu L, Li C, Yu H, Yang X (2022) A critical review on air pollutant exposure and age-related macular degeneration. Sci Total Environ 840:156717PubMedCrossRef
41.
Zurück zum Zitat Klein R, Klein BE, Knudtson MD, Wong TY, Cotch MF, Liu K et al (2006) Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 113(3):373–380PubMedCrossRef Klein R, Klein BE, Knudtson MD, Wong TY, Cotch MF, Liu K et al (2006) Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 113(3):373–380PubMedCrossRef
42.
Zurück zum Zitat Bressler SB, Munoz B, Solomon SD, West SK, Team SEES (2008) Racial differences in the prevalence of age-related macular degeneration: the Salisbury Eye Evaluation (SEE) Project. Arch Ophthalmol 126(2):241–5PubMedCrossRef Bressler SB, Munoz B, Solomon SD, West SK, Team SEES (2008) Racial differences in the prevalence of age-related macular degeneration: the Salisbury Eye Evaluation (SEE) Project. Arch Ophthalmol 126(2):241–5PubMedCrossRef
43.
Zurück zum Zitat Schachat AP, Hyman L, Leske MC, Connell A, Wu S-Y (1995) Features of age-related macular degeneration in a black population. Arch Ophthalmol 113(6):728–735PubMedCrossRef Schachat AP, Hyman L, Leske MC, Connell A, Wu S-Y (1995) Features of age-related macular degeneration in a black population. Arch Ophthalmol 113(6):728–735PubMedCrossRef
44.
Zurück zum Zitat Klein R, Chou C-F, Klein BE, Zhang X, Meuer SM, Saaddine JB (2011) Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol 129(1):75–80PubMedCrossRef Klein R, Chou C-F, Klein BE, Zhang X, Meuer SM, Saaddine JB (2011) Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol 129(1):75–80PubMedCrossRef
45.
Zurück zum Zitat Leske MC, Wu S-Y, Hennis A, Nemesure B, Yang L, Hyman L et al (2006) Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies. Ophthalmology 113(1):29–35PubMedCrossRef Leske MC, Wu S-Y, Hennis A, Nemesure B, Yang L, Hyman L et al (2006) Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies. Ophthalmology 113(1):29–35PubMedCrossRef
46.
Zurück zum Zitat Vanderbeek BL, Zacks DN, Talwar N, Nan B, Musch DC, Stein JD (2011) Racial differences in age-related macular degeneration rates in the United States: a longitudinal analysis of a managed care network. Am J Ophthalmol 152(2):273–82. e3PubMedPubMedCentralCrossRef Vanderbeek BL, Zacks DN, Talwar N, Nan B, Musch DC, Stein JD (2011) Racial differences in age-related macular degeneration rates in the United States: a longitudinal analysis of a managed care network. Am J Ophthalmol 152(2):273–82. e3PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Hageman GS, Hancox LS, Taiber AJ, Gehrs KM, Anderson DH, Johnson LV et al (2006) Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann Med 38(8):592–604PubMedCrossRef Hageman GS, Hancox LS, Taiber AJ, Gehrs KM, Anderson DH, Johnson LV et al (2006) Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann Med 38(8):592–604PubMedCrossRef
48.
Zurück zum Zitat Barbazetto IA, Saroj N, Shapiro H, Wong P, Ho AC, Freund KB (2010) Incidence of new choroidal neovascularization in fellow eyes of patients treated in the MARINA and ANCHOR trials. Am J Ophthalmol 149(6):939–46. e1PubMedCrossRef Barbazetto IA, Saroj N, Shapiro H, Wong P, Ho AC, Freund KB (2010) Incidence of new choroidal neovascularization in fellow eyes of patients treated in the MARINA and ANCHOR trials. Am J Ophthalmol 149(6):939–46. e1PubMedCrossRef
49.
Zurück zum Zitat Gamulescu M-A, Helbig H (2010) Lack of therapeutic effect of ranibizumab in fellow eyes after intravitreal administration. J Ocul Pharmacol Ther 26(2):213–216PubMedCrossRef Gamulescu M-A, Helbig H (2010) Lack of therapeutic effect of ranibizumab in fellow eyes after intravitreal administration. J Ocul Pharmacol Ther 26(2):213–216PubMedCrossRef
50.
Zurück zum Zitat Michalska-Małecka K, Kabiesz A, Kimsa MW, Strzałka-Mrozik B, Formińska-Kapuścik M, Nita M, Mazurek U (2016) Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration. Clin Interv Aging 11:357–65PubMedPubMedCentralCrossRef Michalska-Małecka K, Kabiesz A, Kimsa MW, Strzałka-Mrozik B, Formińska-Kapuścik M, Nita M, Mazurek U (2016) Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration. Clin Interv Aging 11:357–65PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Wu Z, Sadda SR (2008) Effects on the contralateral eye after intravitreal bevacizumab and ranibizumab injections: a case report. Ann Acad Med Singap 37(7):591PubMedCrossRef Wu Z, Sadda SR (2008) Effects on the contralateral eye after intravitreal bevacizumab and ranibizumab injections: a case report. Ann Acad Med Singap 37(7):591PubMedCrossRef
52.
Zurück zum Zitat Rouvas A, Liarakos VS, Theodossiadis P, Papathanassiou M, Petrou P, Ladas I, Vergados I (2009) The effect of intravitreal ranibizumab on the fellow untreated eye with subfoveal scarring due to exudative age-related macular degeneration. Ophthalmologica 223(6):383–389PubMedCrossRef Rouvas A, Liarakos VS, Theodossiadis P, Papathanassiou M, Petrou P, Ladas I, Vergados I (2009) The effect of intravitreal ranibizumab on the fellow untreated eye with subfoveal scarring due to exudative age-related macular degeneration. Ophthalmologica 223(6):383–389PubMedCrossRef
53.
Zurück zum Zitat Semeraro F, Morescalchi F, Duse S, Gambicorti E, Cancarini A, Costagliola C (2015) Pharmacokinetic and pharmacodynamic properties of anti-VEGF drugs after intravitreal injection. Curr Drug Metab 16(7):572–584PubMedCrossRef Semeraro F, Morescalchi F, Duse S, Gambicorti E, Cancarini A, Costagliola C (2015) Pharmacokinetic and pharmacodynamic properties of anti-VEGF drugs after intravitreal injection. Curr Drug Metab 16(7):572–584PubMedCrossRef
54.
Zurück zum Zitat Avery RL, Castellarin AA, Steinle NC, Dhoot DS, Pieramici DJ, See R et al (2014) Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD. Br J Ophthalmol 98(12):1636–1641PubMedCrossRef Avery RL, Castellarin AA, Steinle NC, Dhoot DS, Pieramici DJ, See R et al (2014) Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD. Br J Ophthalmol 98(12):1636–1641PubMedCrossRef
55.
Zurück zum Zitat Zhang C, Wang H, Nie J, Wang F (2014) Protective factors in diabetic retinopathy: focus on blood-retinal barrier. Discov Med 18(98):105–112PubMed Zhang C, Wang H, Nie J, Wang F (2014) Protective factors in diabetic retinopathy: focus on blood-retinal barrier. Discov Med 18(98):105–112PubMed
Metadaten
Titel
Incidence and risk factors of fellow-eyes wet conversion in unilateral neovascular age-related macular degeneration over 15-year follow-up
verfasst von
Elham Sadeghi
Sharat Chandra Vupparaboina
Sandeep Chandra Bollepalli
Kiran Kumar Vupparaboina
Komal Agarwal
Jose-Alain Sahel
Andrew W. Eller
Jay Chhablani
Publikationsdatum
23.08.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 1/2025
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-024-06605-8

Neu im Fachgebiet Augenheilkunde

Künstliche Intelligenz in der Medizin – Chancen und Risiken aus ethischer Sicht

Bildgebende Fächer wie die Augenheilkunde bieten vielfältige Möglichkeiten für den nutzbringenden Einsatz künstlicher Intelligenz (KI). Die Auswertung von Bildern und Daten mittels trainierter Algorithmen besitzt das Potenzial, die …

Okuläre Graft-versus-Host-Disease

Die okuläre Graft-versus-Host-Erkrankung („graft-versus-host disease“ [GVHD]) nach allogener hämatopoetischer Stammzelltransplantation (HSCT) stellt überwiegend eine entzündliche und destruierende Augenoberflächenerkrankung mit zunehmender …

Kataraktchirurgie in Subsahara-Afrika – Möglichkeiten und Grenzen

Die Bedeutung von Sehbeeinträchtigung und Blindheit für Individuen und Gesellschaften hat in den letzten Jahren ein hohes Maß an Aufmerksamkeit erfahren. Wesentliche Aspekte dieser Thematik sind im World report on vision der …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.